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Abstract 
Purpose: To develop and validate a new sensitive and low-cost method for the analysis of amlodipine 
in tablet dosage form using reversed phase high performance liquid chromatography (RP-HPLC) with 
ultraviolet (UV) detection.   
Methods: Standards and samples were prepared by dissolving amlodipine besylate standard or 
amlodipine tablets in mobile phase and sonicated for 5 min. The samples were analysed by RP-HPLC 
equipped with quaternary pump and auto-injector. Separation was achieved using C18 column, and the 
mobile phase consisted of ammonium acetate buffer containing 0.02 % triethylamine TEA (pH = 4, 
adjusted using glacial acetic acid) and acetonitrile in the ratio 60:40 v/v. The flow rate was 1 ml/min and 
a UV detector was used for the detection of amlodipine at a wavelength of 248 nm. The method was 
validated according to International Conference of Harmonization (ICH) guidelines.  
Results: The retention time for amlodipine peak was 3.44 ± 0.41 min with a total run time of 6 min. The 
method was linear over the range of 0.5 - 40 µg/ml with coefficient of determination (R2) of 0.999. 
Recovery was 98.09 - 100.19 %, and the method showed high precision and repeatability. All validated 
parameters were within the range of ICH requirements.  
Conclusion: A new rapid sensitive and low-cost method has been developed and validated for the 
analysis of amlodipine in tablet dosage form.  
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pyridinedicarboxylic acid 3-ethyl 5-methyl ester, a 
third generation dihydropyridine calcium 
antagonist. It is used in the treatment of 
hypertension and coronary artery disease (CAD) 
such as chronic stable angina, vasospastic 
angina (Prinzmetal’s or Variant Angina) and 
angiographically-documented CAD [1]. It was 
firstly formulated by Pfizer under the brand name 
of Norvasc, but several generic versions are now 
available. Amlodipine was combined with several 
drugs in order to enhance their activities or to 
combine more activities. 
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Literature review shows different analytical 
methods for the analysis of amlodipine in 
pharmaceutical preparations or biological fluids 
either as a single drug or in combination with 
other drugs. Those analytical methods include: 
spectrophotometric methods with or without 
derivatization [2-7]. The derivative spectroscopy 
has also been applied for the determination of 
amlodipine and its photodegradant compound 
[8]. Chromatographic methods have been used 
widely for the analysis of amlodipine, including 
thin layer chromatography (TLC) methods [9-12] 
and HPLC methods [13,14]. Capillary 
electrophoresis methods were also used for the 
analysis of amlodipine in its formulations and 
biological fluids [15,16]. Amlodipine was also 
determined using liquid chromatography mass 
spectrometry (LC-MS) [17,18]. .  
 
One of the most important requirements to 
prepare any new formula for existed drugs is to 
develop and validate an analytical method for the 
analysis of the drug in bulk and finished product. 
Some existed methods were tested for the 
analysis of new amlodipine tablet produced but 
they were found not to fulfil the requirements. 
Some of the low-cost methods reported before 
have low sensitivity, whereas the highly-sensitive 
methods are costly. The aim of this study was to 
develop and validate a new, low-cost, highly-
sensitive and specific HPLC method for the 




All the chemicals were of analytical grade and 
the solvents were HPLC grade. Amlodipine 
besylate USP standard with potency of 99.8 % 
was purchased from Sigma. Acetonitrile, 
methanol, phosphoric acid, and triethylamine 
were obtained from Fisher Scientific. Ammonium 
acetate, glacial acetic acid, sodium hydroxide, 
hydrochloric acid, hydrogen peroxide, were all 
purchased from Merck. All solvent were filtered 
using vacuum filtration unit Sartoriuse (Sartorius 
Goettingen, Germany) with Nilon filters (0.45 
µm). Mettler Toledo (USA) analytical balance 
was used.  The pH of the buffers was monitored 
using Mettler Toledo pH meter.  
 
Chromatographic conditions  
 
HPLC (Agilent Technologies USA) equipped with 
Agilent 1200 series quaternary pump and 
vacuum degasser, an Agilent 1200 series auto-
injector with 0.1 – 100 uL variable volume 
injector and an Agilent 1200 series variable 
wavelength detector (VWD). Data processing 
was performed using HP Chem-Station software. 
The samples were injected to the C18 Hypersil 
(3.5 µm, 2.1 × 100 mm) column and the mobile 
phase consisted of ACN: Ammonium acetate 
buffer 0.05 M containing 0.02 % TEA (40:60 v/v) 
and the pH of the buffer was adjusted to pH = 4 
using glacial acetic acid. The flow rate was 1 
ml/min and the detection of amlodipine besylate 
was monitored using UV detector at 248 nm 
wavelength.  
 
Method development   
 
Standard preparation  
 
A stock solution of amlodipine with the 
concentration of 1 mg/ml was prepared by 
transferring 13.87 mg of amlodipine besylate 
(equivalent to 10 mg of amlodipine) into 10 ml 
volumetric flask and 2 ml of mobile phase was 
added and sonicated for 5 min and then cooled 
to the room temperature. The solution was 
diluted to the mark using mobile phase. Further 
dilutions with mobile phase were prepared to 
obtain suitable calibration curve standard in the 
linear range of 0.5-40 µg/ml. 
 
Sample preparation  
 
To prepare the tablet samples, 10 tablets were 
weight and grounded and then the equivalence 
weight of one tablet was transferred into 10 ml 
volumetric flask and mixed with 5 ml of mobile 
phase. The mixture was sonicated for 20 min, 
cooled to the room temperature and then the 
volume was brought to 10 ml using mobile 
phase. The mixture was mixed thoroughly and 
then filtered using Whatman filter paper no. 1. 
Further dilution was carried out using mobile 
phase before injection. 
 
All stock solutions were kept in a refrigerator 
under 4 oC and they were stable for three months 
under such conditions. 
 
Chromatographic analysis  
 
Samples were analysed using Agilent 1200 
Series RP-HPLC equipped with quaternary pump 
and auto injector. UV detector was used for the 
detection, and the wavelength was 248 nm.  
 
Different types of column C8 and C18 were 
tested to choose the best for the analysis. All 
chromatographic parameters were evaluated for 
better separation, including mobile phase 
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composition, pH, flow rate and column 




The developed method was validated according 
to ICH guidelines  [19] to ensure specificity, 
linearity, range, accuracy, precision, limit of 
detection (LOD), limit of quantitation (LOQ) and 
robustness of the method  
 
Forced degradation studies 
 
Forced degradation studies of the drug 
substance can help identify the likely degradation 
products, the stability and specificity of the 
analytical procedure.  
 
Acid degradation studies 
 
A volume of 9 ml of 0.1 M hydrochloric acid 
solution was added to 1 ml of amlodipine 
standard stock solution or to 1 ml of tablet stock 
solution. These solutions were divided into three 
parts and maintained under 4, 50, and 90 oC, the 
portions were allowed to stand for 6 days and 
analysed at intervals over 120 h after dilution to 
10 µg/ml and neutralization using NaOH.  
 
Alkali degradation studies 
 
Sodium hydroxide 0.1 M was used for alkali 
degradation study. A volume of 9 ml of sodium 
hydroxide was added to 1 ml of amlodipine 
standard stock solution or to 1 ml of tablet stock 
solution. These solutions were divided to three 
parts and maintained at 4, 50, and 90 oC; the 
portions were allowed to stand for 6 days and 
analysed at intervals over 120 h after dilution to 
10 µg/ml using mobile phase and neutralization 
using HCl.  
 
Oxidization degradation studies 
 
A volume of 9 ml of 3 % hydrogen peroxide was 
added to 1 ml of amlodipine standard stock 
solution or tablet stock solution. These solutions 
were divided to three parts and maintained at 4, 
50, and 90 oC, the portions were allowed to stand 
for 6 days and analysed at intervals over 120 h 
after dilution to 10 µg/ml.  
 
Temperature stress studies 
 
A 1 ml of amlodipine standard stock solution or 
Amlodipine besylate tablet with concentration of 
1 mg/ml of amlodipine besylate were maintained 
at 4, 50, and 90 oC for 6 days and analysed at 




All data were derived from at least three 
independent experiments. Statistical analysis of 







The optimized chromatographic conditions were 
as follow: the column was C18 Hypersil (3.5 µm, 
2.1 × 100 mm) as it gave the best peak shape 
and the highest reproducibility and repeatability. 
Mobile phase was ACN: Ammonium acetate 
buffer 0.05 M (40:60 v/v) with pH = 4 adjusted 
using glacial acetic acid. The detector used in 
this study was UV/Vis, the wavelength was set at 
λ = 248 nm to reduce the noise which is 
generated by using lower wavelengths. The 
elution was performed at 30 oC with flow rate of 1 
ml /min. The retention time (RT) of amlodipine 
under these conditions was 3.4 min and the full 
run time was optimized to 6 min; Figure 1. 
 
   
Figure 1: Chromatograms obtained from amlodipine 
besylate and placebo (blank) 
 




The specificity of the method was determined by 
injecting the sample solution containing the 
placebo which was prepared by mixing the 
excipients without the amlodipine using same 
amount as the tablet. The method was specific 
for amlodipine upon running the placebo and 
degradation study. The results showed no 
interference from the excipients as shown in 
Figure 1. The results of forced degradation 
studies revealed no interference with the 
degradants peaks also.  
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Linearity solutions were prepared at 7 
concentration levels from 2.5 % to 200 % of 
analyte concentration. The method was linear 
over the range of 0.5 - 40 µg/ml with linear 
regression equation of y = 9.6362x - 1.7689 and 




The accuracy of the method was carried out by 
spiking known amount of amlodipine besylate at 
seven concentration levels ranging from 50 % 
and 150 % of the label claim along with the 
excipients in triplicate. Samples were prepared 
following the sample preparation method 
described above. The recovered amounts were 
in the range of 98.1 - 100.19 % which is within 
the acceptable range according to ICH 
guidelines. The accuracy and recovery results 




Repeatability, intra-day and inter-day precision 
studies were carried out to ensure the precision 
of the method. Precision of the method was 
checked by carrying out six independent assays 
of amlodipine besylate test samples against the 
standard. For repeatability and intraday 
precisions, six replicate of standard solutions 
were injected within same day, while for inter-day 
precision, the samples were injected in different 
days. Two parameters were evaluated for 
precision studies which are area and retention 
time of the peak. The results are shown in Table 
2. 
Table 2: Precision (repeatability, inter-day and 








Intra-day RSD  1.187 0.416 
Inter-day RSD 1.408 0.318 
 
Limit of detection (LOD) and of quantification 
(LOQ)  
 
LOD and LOQ were calculated using the slope 
and standard deviation of standard curve for low 
concentrations of amlodipine. LOD was 17.2 




System suitability parameters were evaluated 
according to ICH guidelines such as USP tailing 
factor, plate number and capacity factor. The 
RSD for repeated sample run was evaluated also 
according to USP method for amlodipine. Table 3 
shows the results for system suitability 
parameters and they are all within the acceptable 
range for ICH and USP guidelines. 
 
Forced degradation studies  
 
The results showed that amlodipine standard and 
amlodipine tablet were stable under room 
temperature, acid hydrolysis, base hydrolysis 
and solvent effect conditions as shown in Figure 
3a, 3b, and 3c. The results also revealed that 
amlodipine standard and tablet are stable under 
50 oC using base hydrolysis as it appears in 
Figure 3b. It is indicated in the results that both 
standard and tablets followed the same path of 
degradation up to 48 h indicating that the 
 
Table 1: Accuracy and recovery of amlodipine in spiked samples 
 
Drug Concentration 50% 70% 80% 100% 120% 130% 150% 
Amount added 
(mg) 5 7 8 10 12 13 15 
Amount 
recovered (mg) 4.928 7.0135 8.011 9.815 11.808 12.752 14.715 
Actual content 
(%) 98.551 100.193 100.140 98.150 98.405 98.096 98.106 
RSD 1.884 1.787 0.998 0.786 0.924 0.257 0.480 
 








RSD for peak area 
for repeated run 
Accepted range  1.022 < 2 2791 > 2000 5.880 > 2 1.028 < 2 
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excipients have no effect on the degradation of 
amlodipine in tablet form. After 48 h and the 
excipients showed some effect in the 
degradation process of amlodipine in tablet form 
using acid and solvent effect degradation and 
this effect appeared significantly after 120 h as 
shown in Figure 3a and 3c. For oxidization, about 
50 % of amlodipine was degraded after 30 h 
under 4 and 50 oC (Figure 3d). Under 90 oC, full 
degradation was achieved using oxidization after 
2 h (Figure 3d), while it needed 120 h to degrade 
the whole amlodipine under acid, base and 
solvent degradation as it is shown in Figure 3a, 
3b and 3c. 
 
Application of proposed method to 
commercial products  
 
The method was applied for three commercial 
products which are: amlodine (S.Y.P. Malaysia), 
Vamlo (Ranbaxy) and iAmlo (formulated in-
house at IIUM Pilot Plant). The samples were 
prepared according to sample preparation 
method described in experimental section and 
analyzed using the developed method. The 
results were shown in Table 4 and they were 




Among others, amlodipine is one of the products 
which has been studied for the quality control 
issues.  This study was designed to develop and 
validate suitable in house analytical method for 
the analysis of amlodipine in the new formulation. 
From the results it can be claimed that the 
developed method was specific, accurate and 
reproducible. The detector used in this study was 




Figure 3: Forced degradation profiles for amlodipine standard and tablet under varying conditions: ♦,  and * 
standard at 4, 50 and 90 oC; □, X, ○ tablets at 4, 50 and 90 oC 
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Table 4: Assay results for the determination of amlodipine in three commercial formulations 
  
Dosage form 













 Sample 1 10 9.947 99.470  
Sample 1 10 9.884 98.840  
Sample 3 10 9.763 97.630  




 Sample 1 5 5.027 100.540  
Sample 1 5 4.930 98.610  
Sample 3 5 4.925 98.500  





Sample 1 10 9.774 97.740 97.020 
Sample 1 10 10.315 103.150 99.360 
Sample 3 10 10.022 100.220 98.920 
Mean(SD)  10.036(0.220) 100.360 98.430(1.020) 
 
ensures that the method is low-cost, and also 
that high reproducibility achieved. LOD and LOQ 
results from this study were comparable with 
those achieved using sophisticated technology. 
The method was linear over the range of 0.5 - 40 
µg/ml with R2 of 0.999 and the linearity was 
evaluated for lower concentrations to find LOD in 
the range of 0.1 - 5 µg/ml with R2 = 0.999.  
 
The method was evaluated for precision and 
reproducibility and the results were in the 
accepted range of ICH guidelines. The method 
was robust upon using different instruments or 
columns. The forced degradation studies showed 
that amlodipine is stable against acid and base 
hydrolysis in room temperature and 50 oC, while 
it is totally unstable due to oxidization by H2O2. 
Comparison of the results obtained in this study 
with results from reference methods indicate that 




A robust, accurate, economic and precise 
method has been developed and validated 
according to ICH guidelines and is suitable for 
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